PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Diazoxide and Raloxifene Interaction

Drug interaction information between Diazoxide and Raloxifene.

Diazoxide and Raloxifene have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Diazoxide and Raloxifene. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.

Drug A

Diazoxide

Potassium Channel Opener (Hyperinsulinism)

Drug B

Raloxifene

Selective Estrogen Receptor Modulator (SERM)

How They Interact

These drugs compete for the same binding spots on proteins in your bloodstream. This competition can change how much of each drug is active in your body at one time.

What To Do

Use this combination with caution. Your healthcare provider may need to monitor your response to these medications more frequently.

FDA Label Information

Highly protein-bound drugs include diazepam, diazoxide, and lidocaine. 7.3 Other Highly Protein-Bound Drugs Raloxifene hydrochloride should be used with caution with certain other highly protein-bound drugs such as diazepam, diazoxide, and lidocaine.

Frequently Asked Questions

Can I take Diazoxide and Raloxifene together?

This is a moderate interaction. Use this combination with caution. Your healthcare provider may need to monitor your response to these medications more frequently.

How serious is the interaction between Diazoxide and Raloxifene?

This interaction is classified as "moderate" severity by the FDA. Moderate interactions may worsen your condition or change how your medications work.

Why do Diazoxide and Raloxifene interact?

These drugs compete for the same binding spots on proteins in your bloodstream. This competition can change how much of each drug is active in your body at one time.

Understanding the Diazoxide and Raloxifene Interaction

FDA-approved prescribing information for these two drugs flags their combination as a moderate-severity interaction. Diazoxide belongs to the Potassium Channel Opener (Hyperinsulinism) class and Raloxifene belongs to the Selective Estrogen Receptor Modulator (SERM) class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: These drugs compete for the same binding spots on proteins in your bloodstream. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Diazoxide has 3 total documented interactions on file in this dataset, and Raloxifene has 7. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Use this combination with caution. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Diazoxide or Raloxifene based on a web page, speak with your prescriber or pharmacist before making any change.

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.